- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Gyrodyne Company of America Inc(GYRO)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for GYRO
11/13/2026: GYRO (1-star) is currently NOT-A-BUY. Pass it for now.
Gyrodyne Company of America Inc is a micro-cap real estate operating company transitioning through an orderly liquidation and asset monetization plan. Its main strength lies in owning valuable commercial and medical office properties in the New York metropolitan area with minimal debt. The core investment story centers on unlocking net asset value through strategic property sales, such as land parcels in Smithtown. However, investors face execution risks, regulatory delays in zoning approvals, and very thin trading liquidity. The stock suits patient special-situation or value-oriented investors who should closely monitor the successful closing of property sales and cash distribution timelines.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Weak fit | The company is executing a liquidation and asset realization plan rather than pursuing traditional long-term operational growth. |
| Momentum investor | Weak fit | Low trading volume and micro-cap status limit short-term momentum appeal unless triggered by specific liquidation announcements. |
| Value investor | Mixed fit | Trading at a discount to estimated net asset value, though realizing that value depends on complex real estate transactions. |
| Dividend investor | Weak fit | Dividends are currently absent or irregular as cash is retained for the winding down of operations. |
| Low-risk investor | Weak fit | Illiquidity, micro-cap volatility, and execution risks surrounding property sales create substantial uncertainty. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | Thin trading liquidity can lead to sharp percentage swings in the share price. |
| Valuation risk | Medium / high | Realized asset values may differ significantly from estimated net asset value projections. |
| Competition risk | Medium | Regional real estate assets compete with other local commercial and medical space alternatives. |
| Business quality | Medium | The operating business model is shifting entirely toward a terminal liquidation phase. |
| Dividend income | Low / none | Income investors cannot rely on regular dividend distributions at this stage. |
| Execution risk | High | Success depends entirely on closing real estate purchase agreements and securing local approvals. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 9.85M USD | Price to earnings Ratio 40.73 | 1Y Target Price - |
Price to earnings Ratio 40.73 | 1Y Target Price - | ||
Volume (30-day avg) 2.2K shares | Beta 0.58 | 52 Weeks Range 3.66 - 9.63 | Updated Date 11/15/2026 |
52 Weeks Range 3.66 - 9.63 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.11 |
Sector & Industry Intelligence
Sector
Real Estate
Constructive- Sentiment
- Strong Bullish
- Momentum
- BUY Breadth Improving
- BUY participation
- 64.5%
- Active BUY / eligible
- 20 / 31
- 30-Day BUY Count Change
- +16
- Market state
- Strong Bullish
More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.
Industry
Real Estate Services
- BUY participation
- 0.0%
- Active BUY / eligible
- 0 / 2
- 30-Day BUY Count Change
- 0
Eligible universe: 2 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Steep Decline
The stock price has dropped sharply with strong downward pressure.

Moderately Choppy
The stock has experienced noticeable price swings while retaining some directional structure.
Analysis of Past Performance
Type Stock | Historic Profit -17.81% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Medical Office Leasing | Rental income generated from healthcare and medical practitioner tenants at properties like Cortlandt Medical Center. | Provides steady rental income, though shrinking as liquidation plans proceed. |
| Industrial and Commercial Leasing | Leasing revenue from multi-tenant industrial and office spaces at the Flowerfield facility. | Serves as a legacy cash flow source prior to final property sales. |
| Asset Monetization | Proceeds from the sale of land parcels and real estate assets under the corporate liquidation plan. | The primary mechanism through which shareholders may ultimately realize returns. |
Valuation
Trailing PE 40.73 | Forward PE - | Enterprise Value 15.69M | Price to Sales(TTM) 3.6 |
Enterprise Value 15.69M | Price to Sales(TTM) 3.6 | ||
Enterprise Value to Revenue 2.59 | Enterprise Value to EBITDA -8.07 | Shares Outstanding 2.20M | Shares Floating 743.09K |
Shares Outstanding 2.20M | Shares Floating 743.09K | ||
Percent Insiders 26.64 | Percent Institutions 42.38 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

